Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats

DSpace Repository

Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats

Author: Koch, Diana A.; Silva, Rodrigo B. M.; de Souza, Alessandra H.; Leite, Carlos E.; Nicoletti, Natalia F.; Campos, Maria M.; Laufer, Stefan; Morrone, Fernanda B.
Tübinger Autor(en):
Koch, Diana A.
Laufer, Stefan
Published in: Rheumatology (2014), Bd. 53, H. 3, S. 425-432
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/rheumatology/ket369
ISSN: 1462-0324
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)